RING THERAPEUTICS
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.
RING THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ringtx.com
Total Employee:
11+
Status:
Active
Total Funding:
167 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
UPMC Enterprises
UPMC Enterprises investment in Series B - Ring Therapeutics
Partners Investment
Partners Investment investment in Series B - Ring Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Ring Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - Ring Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - Ring Therapeutics
Invus
Invus investment in Series B - Ring Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Venture Round - Ring Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | Ring Therapeutics Strengthens Leadership Team with Three Executive Appointments |
Official Site Inspections
http://www.ringtx.com Semrush global rank: 2.99 M Semrush visits lastest month: 5.44 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ring Therapeutics"
Ring Therapeutics: Revolutionizing Medicine with Commensal …
Ring is taking a novel approach to engineering viral-based therapies that can safely and effectively deliver therapies to target cells and tissues. Learn More. Science. Harnessing the …See details»
Join the Team at Ring Therapeutics
We do not interview candidates on Telegram, Wire, Google Hangouts or similar public platforms. Any questions about job listings can be directed to [email protected]. Become a part of our community of pioneers dedicated …See details»
Ring Therapeutics Raises $86.5 Million in Series C Funding to …
Cambridge, Mass. – Mar. 9, 2023 – Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today …See details»
Ring Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, …See details»
Ring Therapeutics - LinkedIn
About us. Powering a new era of gene therapy. An Important Note About Privacy: Ring Therapeutics is committed to your privacy and will not ask for sensitive personal information …See details»
Ring Therapeutics Raises $86.5 Million in Series C Funding to …
Ring Therapeutics. – Ring raised a total of $86.5 million from new and returning investors, validating its unique approach to creating next-generation programable genetic medicines –. – …See details»
Christopher Wright - Chief Medical Officer, & Head of ... - The Org
Chris Wright joined Ring as Chief Medical Officer, Head of Translational Research in February of 2023. Prior to joining Ring, Dr. Wright served as Chief Medical Officer of AavantiBio, Inc., a …See details»
Flagship Unveils Newest Pioneering Platform: Ring …
Dec 19, 2019 · Ring Therapeutics was founded by Flagship Pioneering in 2017 when the firm's entrepreneurial scientists asked: What if we could uncover and harness commensal viruses to deliver nucleic acid...See details»
Ring Therapeutics Presents New Data on Anellogy™ Platform at …
Oct 24, 2023 · Ring Therapeutics is revolutionizing the genetic medicines and nucleic acid medicine space by harnessing the most abundant and diverse member of the human …See details»
Ring Therapeutics - PitchBook
Suite 401. Cambridge, MA 02141. United States. +1 (617) . . Primary Industry. Biotechnology. Other Industries. Drug Discovery. Pharmaceuticals. Discovery Tools (Healthcare)See details»
Flagship Unveils Newest Pioneering Platform ... - Flagship Pioneering
The company is expanding the applications of DNA therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases. For …See details»
Ring Therapeutics - Overview, News & Similar companies
Apr 22, 2024 · Ring Therapeutics contact info: Phone number: (202) 824-5050 Website: www.ringtx.com What does Ring Therapeutics do? Founded in 2017, Ring is developing an in …See details»
Ring Therapeutics - Craft
Ring Therapeutics is a company specializing in the gene therapy. It develops Anellovectors, a redosable and targetable gene therapy platform aiming to harness the human commensal …See details»
Pioneering Research by Scientists at Ring Therapeutics
May 8, 2024 · Pioneering Research by Scientists at Ring Therapeutics. Publications. October 22, 2024. Poster Presentation at ESGCT 2024. AnelloVector (TM) Viral Vectors: encapsidating …See details»
Ring Therapeutics CEO and Key Executive Team | Craft.co
Healthcare - Private. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API. Learn more.See details»
Ring Therapeutics Strengthens Leadership Team with Three
BOSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome …See details»
Ring Therapeutics (@ring_tx) / Twitter
Mar 11, 2019 · We're always looking for talented individuals to join our team. Learn more: http:// bit.ly/3tkuZvG #Anellogy #BeTRUE #LoveisLoveSee details»
Ring Therapeutics: Pioneering the Future
Ring Therapeutics: Pioneering the Future. Mission. Through our limitless imagination of a better future for patients, we aim to redefine possible. Join Our Team. We are. We believe in our …See details»
Ring Therapeutics的公司介绍 | IT桔子 - itjuzi.com
Ring Therapeutics是一个病毒载体技术平台，致力于开发可重复给药的全新病毒载体，已经成功地建立了一个基于共生病毒学的新型平台，创建了一类全新的病毒载体。 北美洲-美国 成立于: …See details»
News & Media - Ring Therapeutics
Jun 7, 2023 · Ring Therapeutics Publishes a Novel Gene Delivery Platform Based on the Commensal Human Anellovirus. October 24, 2023. Ring Therapeutics Presents New Data on …See details»